Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283153 · ClinicalTrials.gov registry record · Phase 2
Affect Recognition: Enhancing Performance of Persons With Acquired Brain Injury (ABI)
A Phase 2 study of Acquired Brain Injury (Including Stroke), sponsored by University at Buffalo.
- Completed
- Registry status
- Phase 2
- Development phase
- 71
- Enrollment target
- 4
- Study locations
NCT00283153 is a Phase 2 study of Acquired Brain Injury (Including Stroke) that has completed, run by University at Buffalo. The registered enrollment target is 71 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT00283153, a Phase 2 study of Acquired Brain Injury (Including Stroke), has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 71 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this research is to evaluate the effectiveness of three training programs designed to teach persons with acquired brain injury (ABI) to recognize emotions. It is hypothesized that the training programs will enhance several aspects of emotion recognition in persons with ABI. Furthermore, it is expected that these effects will be maintained over time, and will positively influence participants' social behavior and integration.
Conditions Studied
Interventions
- BEHAVIORAL Facial Affect Recognition Training
- OTHER Stories of Emotional Inference
Study Locations (4)
New York
- University at Buffalo - Buffalo
North Carolina
- Carolinas HealthCare System - Charlotte
Ontario
- Brock University - St. Catharines
Other
- Massey University - Wellington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2008-10 |
| Est. Completion | 2014-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00283153
The ClinicalTrials.gov registry entry for NCT00283153 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acquired Brain Injury (Including Stroke) appearing as the primary indexed condition, and to 2 interventions - of which Facial Affect Recognition Training is the first listed.
NCT00283153 reports 4 study locations spanning 4 distinct geographic areas - top geographies include New York, North Carolina, Ontario.
Frequently Asked Questions
What is clinical trial NCT00283153 about?
NCT00283153 is a clinical study titled "Affect Recognition: Enhancing Performance of Persons With Acquired Brain Injury (ABI)". The purpose of this research is to evaluate the effectiveness of three training programs designed to teach persons with acquired brain injury (ABI) to recognize emotions. It is hypothesized that the training programs will enhance several aspects of emotion recognition in persons with ABI. Furthermor...
What is the current status of trial NCT00283153?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 71 participants. The study started on 2008-10. Estimated completion is 2014-08.
What conditions does trial NCT00283153 study?
This clinical trial studies the following conditions: Acquired Brain Injury (Including Stroke).
What interventions are being tested in trial NCT00283153?
The interventions under investigation include: Facial Affect Recognition Training (BEHAVIORAL), Stories of Emotional Inference (OTHER).
Who is sponsoring clinical trial NCT00283153?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00283153 being conducted?
This trial has 4 study locations across New York, North Carolina, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.